AVNS
Avanos Medical, Inc.NYSEHealthcare$13.95-0.99%ClosedMarket Cap: $648.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.83
P/S
0.93
EV/EBITDA
-35.28
DCF Value
$-24.84
FCF Yield
6.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
49.8%
Operating Margin
-8.8%
Net Margin
-9.7%
ROE
-8.6%
ROA
-12.1%
ROIC
-6.6%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $180.9M | 47.5% | $-89.3M | $3.7M | $0.08 | — |
| FY 2025 | $701.2M | 49.8% | $-61.6M | $-67.9M | $-1.46 | — |
| Q3 2025 | $177.8M | 45.6% | $13.1M | $-1.4M | $-0.03 | — |
| Q2 2025 | $175.0M | 52.6% | $7.3M | $-76.8M | $-1.66 | — |
| Q1 2025 | $167.5M | 53.6% | $7.3M | $6.6M | $0.14 | — |
| Q4 2024 | $179.6M | 55.3% | $12.5M | $-397.3M | $-8.64 | — |
| FY 2024 | $687.8M | 55.4% | $40.0M | $-392.1M | $-8.53 | — |
| Q3 2024 | $170.4M | 54.5% | $16.7M | $4.3M | $0.09 | — |
| Q2 2024 | $171.7M | 55.7% | $16.1M | $1.8M | $0.04 | — |
| Q1 2024 | $166.1M | 57.1% | $7.4M | $-900.0K | $-0.02 | — |
| Q4 2023 | $173.3M | 54.8% | $22.2M | $10.5M | $0.23 | — |
| FY 2023 | $673.3M | 56.4% | $65.0M | $-61.8M | $-1.33 | — |